A study found GLP-1 drugs such as Zepbound and Wegovy may offer benefits for people living with psoriasis, HealthDay reported Sept. 18.  In the ...

CNBC’s “Fast Money” team discusses new obesity drug data and the market leaders, including Novo Nordisk and Eli Lilly, with ...

Novo Nordisk's Wegovy has shown a 57% greater reduction in cardiovascular risks compared to tirzepatide in a study presented ...

A study analyzing 92,000 people found semaglutides, found in GLP-1 drugs such as Ozempic and Wegovy, were linked to a 33% lower risk of dementia, among other health benefits. Dr. Archina Sadhu, ...

Semaglutide is helping patients achieve weight loss previously achievable only with bariatric surgery. But at what cost?

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Weight loss can be a challenge, even for those who eat healthily and exercise regularly. … ...

An experimental GLP-1 pill called orforglipron promoted substantial weight loss without the need for weekly injections, ...

Patients on daily pill lost about 17% of body weight in trial Results nearly identical to injectable Wegovy New obesity pill ...

Positive results from the trial further indicate that the company is poised to win the next battle in the weight loss drug ...

More than 15 million adults in the United States, or about 4.5% of the population, are using weight loss drugs like Ozempic ...

The WHO has added GLP-1 agonists to its Essential Medicines List in 2025. Learn more about the impact of this decision.

Overall, this study shows that medications like Ozempic, Wegovy, and Mounjaro might help with weight loss not only by ...